- Home
- LICY vs OCX Comparison
LICY vs OCX Comparison
Compare LICY & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICY
- OCX
- Stock Information
- Founded
- LICY 2016
- OCX 2009
- Country
- LICY Canada
- OCX United States
- Employees
- LICY N/A
- OCX N/A
- Industry
- LICY Environmental Services
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LICY Industrials
- OCX Health Care
- Exchange
- LICY Nasdaq
- OCX Nasdaq
- Market Cap
- LICY 35.8M
- OCX 35.1M
- IPO Year
- LICY N/A
- OCX N/A
- Fundamental
- Price
- LICY $0.91
- OCX $2.65
- Analyst Decision
- LICY Hold
- OCX Buy
- Analyst Count
- LICY 2
- OCX 3
- Target Price
- LICY $4.13
- OCX $4.42
- AVG Volume (30 Days)
- LICY 1.3M
- OCX 86.4K
- Earning Date
- LICY 03-14-2025
- OCX 04-11-2025
- Dividend Yield
- LICY N/A
- OCX N/A
- EPS Growth
- LICY N/A
- OCX N/A
- EPS
- LICY N/A
- OCX N/A
- Revenue
- LICY $27,400,000.00
- OCX $709,000.00
- Revenue This Year
- LICY $61.64
- OCX N/A
- Revenue Next Year
- LICY $21.35
- OCX $106.34
- P/E Ratio
- LICY N/A
- OCX N/A
- Revenue Growth
- LICY N/A
- OCX N/A
- 52 Week Low
- LICY $0.77
- OCX $1.92
- 52 Week High
- LICY $15.36
- OCX $3.48
- Technical
- Relative Strength Index (RSI)
- LICY 38.36
- OCX 64.49
- Support Level
- LICY $0.77
- OCX $2.21
- Resistance Level
- LICY $1.05
- OCX $2.85
- Average True Range (ATR)
- LICY 0.08
- OCX 0.22
- MACD
- LICY 0.04
- OCX 0.07
- Stochastic Oscillator
- LICY 48.06
- OCX 77.90
About LICY Li-Cycle Holdings Corp.
Li-Cycle Holdings Corp is a lithium-ion battery resource recovery and lithium-ion battery recycler. The company's proprietary process Spoke and Hub recycling process is designed at its Spokes, to process battery manufacturing scrap and end-of-life batteries to produce black mass and other intermediate products, and at its Hubs, to process black mass to recover raw materials, including but not limited to lithium carbonate, cobalt sulphate, and nickel sulphate.
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.